119 results
DEFA14A
GOSS
Gossamer Bio Inc
24 Apr 24
Additional proxy soliciting materials
4:02pm
“FOR” Proposal 2. 2. Ratification of the appointment of Ernst & Young LLP as our independent registered public accountants for the year ending December 31
8-K
GOSS
Gossamer Bio Inc
12 Mar 24
Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan
4:01pm
and Dr. Nathan is an independent director in accordance with the listing requirements of the Nasdaq Global Select Market.
On March 12, 2024, the Company
S-8
EX-23.1
GOSS
Gossamer Bio Inc
5 Mar 24
Registration of securities for employees
7:37am
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement
S-8
GOSS
Gossamer Bio Inc
5 Mar 24
Registration of securities for employees
7:37am
Plan and form of stock option agreement thereunder
8-K
Consent of Independent Registered Public Accounting Firm - Ernst & Young, LLP
Consent of Latham
8-K
h85jnk
29 Nov 23
Gossamer Bio Announces Appointment of John Quisel, J.D., Ph.D., to its Board of Directors
4:01pm
8-K
EX-3.1
59dbtd vv
27 Nov 23
Departure of Directors or Certain Officers
4:01pm
8-K
EX-10.1
c9sagfpd
27 Nov 23
Departure of Directors or Certain Officers
4:01pm
424B3
rj4xt 7hsud6
28 Aug 23
Prospectus supplement
4:29pm
S-3
9ge76e5ixp3rwtatfwnl
18 Aug 23
Shelf registration
8:41am
S-3
EX-23.1
v3a nki5hzth4dzpf
18 Aug 23
Shelf registration
8:41am
S-3ASR
70zs7a3
17 Aug 23
Automatic shelf registration
4:01pm
S-3ASR
EX-23.1
exh4k 437
17 Aug 23
Automatic shelf registration
4:01pm
8-K
EX-10.1
n66bq fc849spb
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
8-K
EX-4.1
1t40k3t
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm